Dividends

MindBio Therapeutics Corp
does not pay dividends

Shareholder Yield

Current shareholder yield for MBIO is .

Shareholder Yield

Dividends, buybacks and debt paydown, as one yield.

Create a free account · No card needed

Dividend Yield
No dividends
Buyback Yield

Create a free account · No card needed

Debt Paydown Yield

Create a free account · No card needed

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.

This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.

Unlock Buyback Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.

This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.

Unlock Debt Paydown Yield

Peers Comparison
Debt Paydown

Price Appreciation

MBIO Price
MindBio Therapeutics Corp

Annual Price Range
0.09
52w Low
0.065
52w High
3.3
Price Metrics
Average Annual Return 2 012.4%
Standard Deviation of Annual Returns 3 583.45%
Max Drawdown -98%
Shares Statistics
Market Capitalization 691.9k CAD
Shares Outstanding 7 280 000
Percentage of Shares Shorted
N/A

MBIO Return Decomposition
Main factors of price return

Stock Splits

MBIO's latest stock split occurred on Nov 6, 2025

The company executed a 1-for-400 stock split, meaning that for every 400 shares held, investors received 1 new share.

Before the split, MBIO traded at 2 per share. Afterward, the share price was about 2.

The adjusted shares began trading on Nov 6, 2025. This was the only stock split in MBIO's history.

Pre-Split Price
2 2
Post-Split Price
2
Before
After